The Global Embolization Market Is Witnessing High Growth Owing To the High Developments Done By Major Companies in the Market Worldwide

Embolization Market
Embolization Market 

Embolization Market, by Product Type (Particles (Radioembolization Spheres, Drug-eluting Beads, Microspheres (or Blands beads, without drug), and PVA particles (Polyvinyl Alcohol), Liquid Embolic, Plugs, and Coils), by Indication (Hemorrhage/Bleeding, Benign Prostatic Hyperplasia (BPH), Uterine Fibroid, Tumor (Malignant, including Liver Cancer), Malformation (AVM, AVF), Venous embolization (incl. Varicocele forex), and Others), by End User (Hospitals & Clinics, Ambulatory Surgical Centers, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027.

Market Overview:

Embolization is a treatment used to stop bleeding caused by abnormal blood vessels. During embolization, an interventional radiologist (an expert in using x-rays to guide a catheter) inserts a catheter into the abnormal artery or vein and injects special materials or soft metal coils that block blood flow to the vessel. The procedure is less invasive than surgery and most people experience less pain and swelling after a procedure and can return to their normal activities quickly.

The Embolization Market is predicted to reach US$ 1,433.6 million in 2020 and grow at a CAGR of 8.1% during the forecast period (2020-2027).

Competitive Landscape:

Major players operating in the global Embolization Market include Stryker Corporation, Johnson & Johnson, Medtronic, Terumo Medical Systems, Boston Medical Corporation, IMbiotechnologies Ltd., Emboline, Inc., Rapid Medical, Artio Medical Inc., Shape Memory Medical Inc., Cardiva, Meril Life Sciences Pvt. Ltd., Merit Medical Systems, Penumbra, Inc., Kaneka Corporation, Cook Medical, Balt, Acandis GmbH, Abbott Laboratories, and Sirtex Medical Limited.

Key Market Drivers:

Increasing developments by key players in the global embolization for market are expected to augment the growth of the market. For instance, in April 2021, the United States Food and Drug Administration (FDA) approved Medtronic PLC's Pipeline Flex Embolization Device with Shield Technology, for treating brain aneurysms.

Before embolization, patients will be going through an ultrasound or CT scan to see the arteries and veins in the body that are affected by the disease. Patients also are told to stop taking certain medicines, such as blood thinners, for a few days before the procedure. Moreover, the high incidence of chronic diseases such as neurovascular diseases, cardiovascular diseases, and cancer is estimated to enhance the growth of the global embolization market.

Covid-19 Impact Analysis:

During the COVID-19 pandemic, there have been several developments in the global embolization market. For instance, in July 2021, Terumo Medical Corporation launched the first and only micro catheter plug called AZUR Vascular Plug.

The global Vascular Embolization Market is anticipated to increase over the course of the projected period as vascular illnesses become more prevalent around the world.

Key Takeaways:

· North America is expected to dominate the growth of the global Embolization Market, owing to the high prevalence of key companies in the region. For instance, in March 2021, Boston Scientific received the approval of the United States Food and Drug Administration (FDA) for its TheraSphere Y-90 Glass Microspheres.

· The Asia Pacific is estimated to witness high growth in the global embolization for market, owing to the increasing rate of developments by major players in the region. For instance, in January 2021, Terumo Corporation received the approval of the U.S. Food and Drug Administration for its PMA Supplement for the WEB 17 System. This is a new addition to the company’s WEB Aneurysm Embolization System.

Comments

Post a Comment

Popular posts from this blog

Sarcopenia Treatment; Training and Physical Exercise Is Key to Counteract Sarcopenia

Image
Sarcopenia Treatment A primary Sarcopenia Treatment is exercise. Researchers have identified resistance training as the specific form of exercise that is most beneficial to individuals with sarcopenia. At present, resistance exercise, protein supplementation, and vitamin D have been established as the basic treatment of sarcopenia. Recent clinical trials on sarcopenia therapies such as physical exercise, nutraceutical, and pharmaceutical interventions have revealed that exercise is the only effective strategy shown to alleviate sarcopenia. Sarcopenia refers to a loss of muscle mass specifically related to aging. It's normal to lose some muscle mass as people age. Sarcopenia has been defined as an age-related, involuntary loss of skeletal muscle mass and strength. Although aging is the main cause of sarcopenia, some other factors contribute to the loss of muscle mass. Getting little or no physical activity on a regular basis puts people at an increased risk of developing sarcopenia
Read more

Bioresorbable Implants Can Also Help To Prevent Complications And Speed Up The Recovery Process

Image
Bioresorbable Implants Medical implants, either passive for structural support or for diagnosis and therapy with active electronics, are widely used in surgical applications. Although they have shown long-term biocompatibility, their removal imposes physical, biological and economical burdens on patients. To overcome this drawback, implantable devices exhibiting biodegradation in the body have been developed. These implants disappear inside the body after a certain time of use, and can be replaced with natural bone. The resorption of Bioresorbable Implants is driven by hydrolysis of the bonds linking their monomers. The amorphous portions of the polymer degrade first, while the crystalline regions remain intact and provide most of their mechanical strength. The monomers are then broken down into lactic and glycolic acids, which are converted to pyruvate and then processed through the citric acid cycle into water and carbon dioxide. The Bioresorbable Implants Market was valued at US$
Read more

Increasing Developments by Key Players Are Expected To Augment the Growth of the Global Digital Pathology Market

Image
 Digital Pathology Digital Pathology Market , by Product Type (Image Analysis Software, Scanner {Bright Field Scanner, Fluorescence Scanner}, Services {Installation & Integration, Maintenance Services, Consulting Services}), by Therapeutic Area (Oncology, Hematology, Autoimmune Disorder, Dermatology, and Others), by Technology (Immunohistochemistry, ISH & FISH, Immunofluorescence and others) End User (Pharmaceutical & Biotechnology Companies, Diagnostic Labs, Hospital Laboratories, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030. The global Digital Pathology Market is anticipated to reach an estimated value of US$ 884.4 million in 2023 and is projected to grow at a CAGR of 12.2% from 2023 to 2030. Market Overview: Digital pathology refers to the practice of digitizing glass slides containing tissue samples and analyzing them using digital imaging technology
Read more